|
1
|
Timmermans F, Plum J, Yöder MC, Ingram DA,
Vandekerckhove B and Case J: Endothelial progenitor cells: Identity
defined? J Cell Mol Med. 13:87–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kang SD, Carlon TA, Jantzen AE, Lin FH,
Ley MM, Allen JD, Stabler TV, Haley NR, Truskey GA and Achneck HE:
Isolation of functional human endothelial cells from small volumes
of umbilical cord blood. Ann Biomed Eng. 41:2181–2192. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kalka C, Masuda H, Takahashi T, Kalka-Moll
WM, Silver M, Kearney M, Li T, Isner JM and Asahara T:
Transplantation of ex vivo expanded endothelial progenitor cells
for therapeutic neovascularization. Proc Natl Acad Sci USA. 97:pp.
3422–3427. 2000; View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fan CL, Li Y, Gao PJ, Liu JJ, Zhang XJ and
Zhu DL: Differentiation of endothelial progenitor cells from human
umbilical cord blood CD 34+ cells in vitro. Acta
Pharmacol Sin. 24:212–218. 2003.PubMed/NCBI
|
|
5
|
Rafii S and Lyden D: Therapeutic stem and
progenitor cell transplantation for organ vascularization and
regeneration. Nat Med. 9:702–712. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Toma C, Pittenger MF, Cahill KS, Byrne BJ
and Kessler PD: Human mesenchymal stem cells differentiate to a
cardiomyocyte phenotype in the adult murine heart. Circulation.
105:93–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Secco M, Zucconi E, Vieira NM, Fogaça LL,
Cerqueira A, Carvalho MD, Jazedje T, Okamoto OK, Muotri AR and Zatz
M: Multipotent stem cells from umbilical cord: Cord is richer than
blood! Stem Cells. 26:1–150. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bongso A, Fong CY and Gauthaman K: Taking
stem cells to the clinic: Major challenges. J Cell Biochem.
105:1352–1360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hayward CJ, Fradette J, Galbraith T, Rémy
M, Guignard R, Gauvin R, Germain L and Auger FA: Harvesting the
potential of the human umbilical cord: Isolation and
characterisation of four cell types for tissue engineering
applications. Cells Tissues Organs. 197:37–54. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang SH, Lin SJ, Chen YH, Lin FY, Shih JC,
Wu CC, Wu HL and Chen YL: Late outgrowth endothelial cells derived
from Wharton jelly in human umbilical cord reduce neointimal
formation after vascular injury: Involvement of pigment
epithelium-derived factor. Arterioscler Thromb Vasc Biol.
29:816–822. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chao KC, Chao KF, Fu YS and Liu SH:
Islet-like clusters derived from mesenchymal stem cells in
Wharton's Jelly of the human umbilical cord for transplantation to
control type 1 diabetes. PLoS One. 3:e14512008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang H, Zhang B, Tao Y, Cheng M, Hu J, Xu
M and Chen H: Isolation and characterization of mesenchymal stem
cells from whole human umbilical cord applying a single enzyme
approach. Cell Biochem Funct. 30:643–649. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang HS, Hung SC, Peng ST, Huang CC, Wei
HM, Guo YJ, Fu YS, Lai MC and Chen CC: Mesenchymal stem cells in
the Wharton's jelly of the human umbilical cord. Stem Cells.
22:1330–1337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sarugaser R, Lickorish D, Baksh D,
Hosseini MM and Davies JE: Human umbilical cord perivascular
(HUCPV) cells: A source of mesenchymal progenitors. Stem Cells.
23:220–229. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Kimura T, Asada R, Harada S,
Yokota S, Kawamoto Y, Fujimura Y, Tsuji T, Ikehara S and Sonoda Y:
SCID-repopulating cell activity of human cord blood-derived
CD34-cells assured by intra-bone marrow injection. Blood.
101:2924–2931. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yahata T, Ando K, Sato T, Miyatake H,
Nakamura Y, Muguruma Y, Kato S and Hotta T: A highly sensitive
strategy for SCID-repopulating cell assay by direct injection of
primitive human hematopoietic cells into NOD/SCID mice bone marrow.
Blood. 101:2905–2913. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ,
Hwang KK, Oh BH, Lee MM and Park YB: Characterization of two types
of endothelial progenitor cells and their different contributions
to neovasculogenesis. Arterioscler Thromb Vasc Biol. 24:288–293.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Murga M, Yao L and Tosato G: Derivation of
endothelial cells from CD34-umbilical cord blood. Stem Cells.
22:385–395. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moon SH, Kim SM, Park SJ, Kim H, Bae D,
Choi YS and Chung HM: Development of a xeno-free autologous culture
system for endothelial progenitor cells derived from human
umbilical cord blood. PLoS One. 8:e752242013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang ZW, Liu N, Li D, Zhang HY, Wang Y,
Liu Y, Zhang LL and Ju XL: Angiopoietin-1 modified human umbilical
cord mesenchymal stem cell therapy for endotoxin-induced acute lung
injury in rats. Yonsei Med J. 58:206–216. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee MJ, Yoon TG, Kang M, Kim HJ and Kang
KS: Effect of subcutaneous treatment with human umbilical cord
blood-derived multipotent stem cells on peripheral neuropathic pain
in rats. Korean J Physiol Pharmacol. 21:153–160. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kumbhar SG and Pawar SH: Synthesis and
characterization of chitosan-alginate scaffolds for seeding human
umbilical cord derived mesenchymal stem cells. Biomed Mater Eng.
27:561–575. 2016.PubMed/NCBI
|
|
24
|
Marupanthorn K, Tantrawatpan C, Kheolamai
P, Tantikanlayaporn D and Manochantr S: Bone morphogenetic
protein-2 enhances the osteogenic differentiation capacity of
mesenchymal stromal cells derived from human bone marrow and
umbilical cord. Int J Mol Med. 39:654–662. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yin C, Liang Y, Zhang J, Ruan G, Li Z,
Pang R and Pan X: Umbilical cord-derived mesenchymal stem cells
relieve hindlimb ischemia through enhancing Angiogenesis in tree
shrews. Stem Cells Int. 2016:97420342016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zayed SA, Gaafar TM, Samy RM, Sabry D,
Nasr AS and Maksoud FA: Production of endothelial progenitor cells
obtained from human Wharton's jelly using different culture
conditions. Biotech Histochem. 91:532–539. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meng X, Xue M, Xu P, Hu F, Sun B and Xiao
Z: MicroRNA profiling analysis revealed different cellular
senescence mechanisms in human mesenchymal stem cells derived from
different origin. Genomics. 109:147–157. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lo Iacono M, Anzalone R, La Rocca G,
Baiamonte E, Maggio A and Acuto S: Wharton's jelly mesenchymal
stromal cells as a feeder layer for the ex vivo expansion of
hematopoietic stem and progenitor cells: A review. Stem Cell Rev.
13:35–49. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fellows CR, Matta C, Zakany R, Khan IM and
Mobasheri A: Adipose, bone marrow and synovial joint-derived
mesenchymal stem cells for cartilage repair. Front Genet.
7:2132016. View Article : Google Scholar : PubMed/NCBI
|
